[go: up one dir, main page]

DE69627706D1 - Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon-freisetzungsfaktor - Google Patents

Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon-freisetzungsfaktor

Info

Publication number
DE69627706D1
DE69627706D1 DE69627706T DE69627706T DE69627706D1 DE 69627706 D1 DE69627706 D1 DE 69627706D1 DE 69627706 T DE69627706 T DE 69627706T DE 69627706 T DE69627706 T DE 69627706T DE 69627706 D1 DE69627706 D1 DE 69627706D1
Authority
DE
Germany
Prior art keywords
growth hormone
release
hormone releasing
aqueous composition
releasing factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69627706T
Other languages
English (en)
Other versions
DE69627706T2 (de
Inventor
P Foster
M Moseley
F Caputo
J Hageman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69627706D1 publication Critical patent/DE69627706D1/de
Publication of DE69627706T2 publication Critical patent/DE69627706T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69627706T 1996-01-11 1996-12-13 Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon-freisetzungsfaktor Expired - Fee Related DE69627706T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US973896P 1996-01-11 1996-01-11
US9738P 1996-01-11
PCT/US1996/019417 WO1997025057A1 (en) 1996-01-11 1996-12-13 Aqueous prolonged release formulation

Publications (2)

Publication Number Publication Date
DE69627706D1 true DE69627706D1 (de) 2003-05-28
DE69627706T2 DE69627706T2 (de) 2004-02-05

Family

ID=21739423

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69627706T Expired - Fee Related DE69627706T2 (de) 1996-01-11 1996-12-13 Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon-freisetzungsfaktor

Country Status (14)

Country Link
US (2) US6150330A (de)
EP (1) EP0873134B1 (de)
JP (1) JP2000506509A (de)
KR (1) KR100445087B1 (de)
CN (1) CN1130222C (de)
AT (1) ATE238063T1 (de)
CA (1) CA2240685A1 (de)
DE (1) DE69627706T2 (de)
DK (1) DK0873134T3 (de)
ES (1) ES2197258T3 (de)
HK (1) HK1016083A1 (de)
NZ (1) NZ326953A (de)
PT (1) PT873134E (de)
WO (1) WO1997025057A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69627706T2 (de) * 1996-01-11 2004-02-05 Pharmacia & Upjohn Co., Kalamazoo Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon-freisetzungsfaktor
EP1355941A2 (de) * 2001-02-02 2003-10-29 ConjuChem, Inc. Langwirkende derivate des wachstumshormon freisetzenden faktors
CN1688696A (zh) * 2002-09-18 2005-10-26 蒙特利尔大学医疗中心 Ghrh类似物
US8871713B2 (en) 2013-03-01 2014-10-28 Theratechnologies Inc. Formulations of growth hormone releasing factor (GRF) molecules with improved stability
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
EP4477215A3 (de) 2020-12-08 2025-02-19 Ruminant Biotech Corp Limited Verbesserungen an vorrichtungen und verfahren zur abgabe von substanzen an tiere

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8702440A1 (es) * 1984-10-04 1986-12-16 Monsanto Co Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa.
US4977140A (en) * 1985-08-23 1990-12-11 Eli Lilly And Company Injectable sustained release formulation
DK0477217T3 (da) * 1989-06-16 1995-04-03 Upjohn Co Stabiliserede, potente GRF-analoge
US5756458A (en) * 1989-06-16 1998-05-26 Pharmacia & Upjohn Company Stabilized potent GRF analogs
JPH06500311A (ja) * 1990-06-29 1994-01-13 エフ・ホフマン―ラ　ロシュ　アーゲー ヒスチジン置換されたヒト成長ホルモン放出因子類縁体
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
DK0661989T3 (da) * 1992-09-21 1998-03-02 Upjohn Co Proteinsammensætninger med vedvarende frigivelse
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
DE69627706T2 (de) * 1996-01-11 2004-02-05 Pharmacia & Upjohn Co., Kalamazoo Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon-freisetzungsfaktor

Also Published As

Publication number Publication date
EP0873134B1 (de) 2003-04-23
US6429195B1 (en) 2002-08-06
WO1997025057A1 (en) 1997-07-17
ES2197258T3 (es) 2004-01-01
ATE238063T1 (de) 2003-05-15
AU705466B2 (en) 1999-05-20
KR100445087B1 (ko) 2004-10-15
JP2000506509A (ja) 2000-05-30
DK0873134T3 (da) 2003-08-11
PT873134E (pt) 2003-08-29
DE69627706T2 (de) 2004-02-05
CN1202114A (zh) 1998-12-16
AU1564997A (en) 1997-08-01
CA2240685A1 (en) 1997-07-17
KR19990077154A (ko) 1999-10-25
HK1016083A1 (en) 1999-10-29
CN1130222C (zh) 2003-12-10
US6150330A (en) 2000-11-21
EP0873134A1 (de) 1998-10-28
NZ326953A (en) 2001-03-30

Similar Documents

Publication Publication Date Title
DE69212497D1 (de) Glasartige kohlenhydratenmatrize zur verabreichung von heilmitteln mit verzögerter wirkstoffabgabe
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
DK336986D0 (da) Fremgangsmaade til fremstilling af toerre biologisk aktive rekombinante vaeksthormoner
ATE298561T1 (de) Orale dareichungsform
MY125556A (en) Aqueous formulations of peptide
Gona Prolactin as a goitrogenic agent in amphibia
RU98117135A (ru) Композиция стабилизированного гормона роста и способ ее приготовления
DE68928528D1 (de) Verwendung von GnRH, LHRH oder ihre Derivate enthaltende Zubereitungen mit verzögerter Wirkstofffreisetzung
DE69627706D1 (de) Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon-freisetzungsfaktor
DE69513635D1 (de) Wässrige zubereitung mit verzögerter wirkstofffreigabe
KR860006982A (ko) 안정한 감마 인터페론 제형의 제조방법
GB8603964D0 (en) Compositions
BR9911756A (pt) Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto
CA2072797A1 (en) Use of tri (n-butyl) phosphate at low ph in solutions of biologically active proteins for enhanced virucidal activity
Klindt et al. Plasma concentration of thyrotropin-releasing hormone, thyrotropin, prolactin, and growth hormone during five-day osmotic pump infusion of thyrotropin-releasing hormone
WO2000032224A3 (en) Calcitonin for the modulation of sperm function
Brandt Jr et al. Effect of implantation and melengestrol acetate feeding on blood serum profiles and performance of heifers
KR880009663A (ko) 돼지의 성장 촉진 방법
TH48412A3 (th) องค์ประกอบสารกระตุ้นการเจริญเติบโต ที่ได้รับการปรับปรุง
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee